Condition

De Novo (2)

Age More 60yr (1)

Leukemia, Myeloid, Acute (1)

Low-dose Corticosteroids Pretreatment (1)

Restenoses, Coronary (1)

Secondary (1)

Symptomatic Ischemic Heart Disease (1)

Untreated Philadelphia Positive Acute Lymphoblastic Leukemia (1)

de Novo (1)

Overall Status

Completed (1)

Recruiting (1)

Unknown status (1)

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Biotronik AG (1)

Gruppo Italiano Malattie EMatologiche dell'Adulto (1)

PETHEMA Foundation (1)

Collaborator

Study Documents

Intervention Type

drug (2)

device (1)

procedure (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Observational (1)

de novo

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Untreated Philadelphia Positive Acute Lymphoblastic Leukemia, De Novo, Secondary Trial in Italy (Prephase PDN + CY, Cycle 1

Completed

Untreated Philadelphia Positive Acute Lymphoblastic Leukemia
+3 more

Prephase PDN + CY
+10 more

Alessandria, Italy
+60 more

Sep 6, 2021

Leukemia, Myeloid, Acute, De Novo, Age More 60yr Trial in Spain (Azacitidine, Venetoclax, Quizartinib)

Recruiting

Leukemia, Myeloid, Acute
+2 more

Azacitidine
+3 more

Alcalá De Henares, Spain
+14 more

May 17, 2021

BIOFLOW-SV All Comers Registry

Unknown status

de Novo
+2 more

Orsiro Sirolimus Eluting Coronary Stent System

Porto Alegre, Brazil
+1 more

Sep 12, 2018